Sertraline Hydrochloride Patent Expiration

Sertraline Hydrochloride is Used for treating disorders of the serotonergic system such as depression and anxiety-related disorders. It was first introduced by Viatris Specialty Llc in its drug Zoloft on Dec 30, 1991. Another drug containing Sertraline Hydrochloride is Sertraline Hydrochloride. 27 different companies have introduced drugs containing Sertraline Hydrochloride.

Sertraline Hydrochloride Patents

Given below is the list of patents protecting Sertraline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Zoloft	US6727283 (Pediatric)	Sertraline oral concentrate	Apr 11, 2020 (Expired)	Viatris
Zoloft	US7067555 (Pediatric)	Sertraline oral concentrate	Apr 11, 2020 (Expired)	Viatris
Zoloft	US6727283	Sertraline oral concentrate	Oct 11, 2019 (Expired)	Viatris
Zoloft	US7067555	Sertraline oral concentrate	Oct 11, 2019 (Expired)	Viatris
Zoloft	US5248699 (Pediatric)	Sertraline polymorph	Feb 13, 2013 (Expired)	Viatris
Zoloft	US5248699	Sertraline polymorph	Aug 13, 2012 (Expired)	Viatris

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sertraline Hydrochloride's patents.

Latest Legal Activities on Sertraline Hydrochloride's Patents

Given below is the list recent legal activities going on the following patents of Sertraline Hydrochloride.

Activity	Date	Patent Number

Payment of Maintenance Fee, 12th Year, Large Entity	20 Nov, 2017	US7067555
Patent Issue Date Used in PTA Calculation Critical	27 Jun, 2006	US7067555
Recordation of Patent Grant Mailed Critical	27 Jun, 2006	US7067555
Issue Notification Mailed Critical	07 Jun, 2006	US7067555
Dispatch to FDC	01 Jun, 2006	US7067555
Application Is Considered Ready for Issue Critical	04 May, 2006	US7067555
Mail Examiner's Amendment	17 Apr, 2006	US7067555
Pubs Case Remand to TC Critical	13 Jan, 2006	US7067555
Issue Fee Payment Received Critical	07 Nov, 2005	US7067555
Issue Fee Payment Verified Critical	07 Nov, 2005	US7067555

Sertraline Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Sertraline Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Sertraline Hydrochloride. The first generic version for Sertraline Hydrochloride was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jun 30, 2006. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on May 3, 2021.

Given below is the list of companies who have filed for Sertraline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.

1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Nov 7, 2014
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Nov 7, 2014
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Nov 7, 2014

2. ANDA REPOSITORY

Anda Repository Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

3. APPCO

Appco Pharma Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

Manufacturing Plant Locations
^New

Appco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Appco as present at those locations.

Country

City

Firm Name

United States

Somerset	Appco Pharma, LLC
Piscataway	Appco Pharma LLC

4. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE	tablet	Prescription	ORAL	AB	May 3, 2021
EQ 50MG BASE	tablet	Prescription	ORAL	AB	May 3, 2021
EQ 25MG BASE	tablet	Prescription	ORAL	AB	May 3, 2021

5. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 20MG BASE/ML	concentrate	Prescription	ORAL	AA	Oct 31, 2008

Manufacturing Plant Locations
^New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country

City

Firm Name

India

Sangareddy	Aurobindo Pharma Limited
Polepally, Mahaboob Nagar	Aurobindo Pharma Limited
Medchal	Aurobindo Pharma Ltd
Bachupally	Aurobindo Pharma Limited

United States

East Windsor

Aurobindo Pharma USA Inc

6. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

7. GRANULES

Granules India Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Granules.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Jan 8, 2008
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Jan 8, 2008
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Jan 8, 2008

Manufacturing Plant Locations
^New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country

City

Firm Name

United States

Chantilly	Granules Pharmaceuticals Inc.
Manassas	Granules Consumer Health Inc.

India

Sangareddy District	Granules India Limited
Parawada Mandal	Granules India Limited
Medchal-Malkhajgiri District	Granules India Limited
Visakhapatnam	Granules India Limited
Secunderabad	Granules India Limited

8. HERITAGE PHARMA AVET

Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage Pharma Avet.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

9. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Aug 10, 2009
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Aug 10, 2009
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Aug 10, 2009

10. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007

11. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Jun 30, 2006
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Jun 30, 2006
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Jun 30, 2006

12. LUPIN

Lupin Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007

Manufacturing Plant Locations
^New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country

City

Firm Name

India

Mumbai	Lupin Limited
Dabhasa	LUPIN MANUFACTURING SOLUTIONS LIMITED
Pirangut	Lupin Limited
Tarapur, Thane	Lupin Limited
Anakapalli District	Lupin Manufacturing Solutions Limited
Navi Mumbai	LUPIN LIMITED
Vasco Da Gama	Lupin Limited
Pune	Lupin Bioresearch Center
Mandideep	Lupin Limited (Unit II)
Aurangabad	Lupin Ltd.
Mandideep	Lupin Limited
Nagpur	Lupin Limited
Pithampur	Lupin Limited
Pithampur	Lupin Limited (Unit 1)

United States

Coral Springs	Lupin Research Inc
Baltimore	Lupin Pharmaceuticals Inc.

13. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Mar 20, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Mar 20, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Mar 20, 2007

14. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Jan 31, 2008
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Jan 31, 2008
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Jan 31, 2008

15. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Jul 21, 2010
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Jul 21, 2010
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Jul 21, 2010

16. PHARMOBEDIENT

Pharmobedient Consulting Llc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharmobedient.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

17. RANBAXY LABS LTD

Ranbaxy Laboratories Ltd has filed for 1 generic for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Ranbaxy Labs Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 20MG BASE/ML	concentrate	Discontinued	ORAL	N/A	Feb 5, 2007

18. REYOUNG

Reyoung Corporation has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Reyoung.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Mar 4, 2009
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Mar 4, 2009
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Mar 4, 2009

19. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Apr 30, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Apr 30, 2007
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Apr 30, 2007

20. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 20MG BASE/ML	concentrate	Prescription	ORAL	AA	Jun 30, 2006
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007

Manufacturing Plant Locations
^New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country

City

Firm Name

United States

East Brunswick	Strides Pharma Inc.
Chestnut Ridge	Strides Pharma, Inc.

India

Bangalore	Strides Pharma Science Limited
Puducherry	Strides Pharma Science Limited

21. SUN PHARM INDS (IN)

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds (in).

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

22. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 150MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 200MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

23. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

24. VIWIT PHARM

Viwit Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Viwit Pharm.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Feb 6, 2007

Manufacturing Plant Locations
^New

Viwit Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Viwit Pharm as present at those locations.

Country

City

Firm Name

China

Tengzhou

Viwit Pharmaceutical Co., Ltd.

25. ZYDUS

Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Sertraline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Feb 6, 2007

Manufacturing Plant Locations
^New

Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.

Country

City

Firm Name

India

Jarod	Zydus Lifesciences Limited
Matoda	Zydus Lifesciences Limited
Matoda, Ahmedabad	Zydus Animal Health and Investments Limited
Ankleshwar	Zydus Lifesciences Limited
District Solan	Zydus Lifesciences Limited
Thane	Zydus Lifesciences Limited
Ahmedabad	ZYDUS LIFESCIENCES LIMITED
Matoda	Zydus Hospira Oncology Private Ltd.
Moraiya, Ahmedabad	Zydus Lifesciences Limited
Dabhasa	Zydus Lifesciences Limited
Ahmedabad	Zydus Lifesciences Limited

United States

Pennington

Zydus Pharmaceuticals (USA) Inc

Pharsight

Pharsight

Sertraline Hydrochloride Patents

Latest Legal Activities on Sertraline Hydrochloride's Patents

Sertraline Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Sertraline Hydrochloride Generic API Manufacturers

1. ACCORD HLTHCARE

2. ANDA REPOSITORY

3. APPCO

Manufacturing Plant Locations New

4. ASCENT PHARMS INC

5. AUROBINDO PHARMA

Manufacturing Plant Locations New

6. CHARTWELL MOLECULAR

7. GRANULES

Manufacturing Plant Locations New

8. HERITAGE PHARMA AVET

9. HIKMA PHARMS

10. INVAGEN PHARMS

11. IVAX SUB TEVA PHARMS

12. LUPIN

Manufacturing Plant Locations New

13. MYLAN PHARMS INC

14. NORVIUM BIOSCIENCE

15. OXFORD PHARMS

16. PHARMOBEDIENT

17. RANBAXY LABS LTD

18. REYOUNG

19. SCIEGEN PHARMS INC

20. STRIDES PHARMA

Manufacturing Plant Locations New

21. SUN PHARM INDS (IN)

22. SUN PHARM INDS LTD

23. TORRENT PHARMS

24. VIWIT PHARM

Manufacturing Plant Locations New

25. ZYDUS

Manufacturing Plant Locations New

Related content

Have Questions?

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New